Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Management of Cognitive Symptoms with White Matter T2 Hyperintensities

Initial Diagnostic Workup

  • A thorough cognitive assessment should be conducted as part of Tier 1 testing for etiological diagnosis, as structural brain imaging alone is insufficient to determine the cause of cognitive symptoms, according to the Alzheimer's and Dementia guidelines 1
  • Neuropsychological testing should focus on memory, executive function, and attention domains, as white matter hyperintensities (WMHs) are associated with executive dysfunction, as recommended by the Alzheimer's and Dementia society 2
  • Evaluate for vascular risk factors (hypertension, diabetes, hyperlipidemia, smoking) as these are strongly associated with white matter changes, as stated by the American College of Radiology guidelines 3, 4

Interpretation of MRI Findings

  • The interpretation of structural brain imaging must take into consideration the patient's age, as aging itself can be associated with relatively minimal/mild and diffuse leukoaraiosis (white matter changes), according to the Alzheimer's and Dementia guidelines 1
  • The location and pattern of WMHs are important - frontal predominance may suggest vascular cognitive impairment, as suggested by the American College of Radiology guidelines 5

Additional Testing to Consider

  • Laboratory evaluation should include assessment of metabolic, infectious, and inflammatory causes of white matter changes, as recommended by the Clinical Infectious Diseases society 6
  • Consider APOE genotyping as APOE status may modify the relationship between WMHs and cognitive outcomes, according to the Alzheimer's and Dementia guidelines 2
  • If clinical suspicion for neurodegenerative disease is high, consider FDG-PET/CT brain imaging to differentiate vascular cognitive impairment from other causes of cognitive decline, as stated by the American College of Radiology guidelines 3

Management Approach

  • Address modifiable vascular risk factors aggressively to prevent progression of white matter disease, as recommended by the American College of Radiology guidelines 4
  • Consider cognitive rehabilitation strategies focused on executive function domains, according to the Alzheimer's and Dementia society 2
  • Establish a dialogue with the patient about her understanding of the cognitive symptoms and MRI findings to guide education and future management, as suggested by the Alzheimer's and Dementia guidelines 1
  • Schedule regular follow-up with repeat cognitive assessment to monitor for progression, as recommended by the Alzheimer's and Dementia guidelines 1

Important Considerations

  • The presence of WMHs alone does not establish a diagnosis of vascular cognitive impairment or dementia, as stated by the American College of Radiology guidelines 3
  • WMHs should not be routinely interpreted as "age-related" in a patient with cognitive symptoms, particularly if not obviously minimal/very mild and diffuse, according to the Alzheimer's and Dementia guidelines 1
  • The relationship between subjective memory complaints and WMHs may be influenced by factors such as depression and anxiety, which should be assessed, as recommended by the Alzheimer's and Dementia society 2